Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Health and Health Determinant Metrics for Cities: A Comparison of County and City-Level Data.
Spoer BR, Feldman JM, Gofine ML, Levine SE, Wilson AR, Breslin SB, Thorpe LE, Gourevitch MN. Spoer BR, et al. Among authors: breslin sb. Prev Chronic Dis. 2020 Nov 5;17:E137. doi: 10.5888/pcd17.200125. Prev Chronic Dis. 2020. PMID: 33155973 Free PMC article.
Research ethics for mobile sensing device use by vulnerable populations.
Breslin S, Shareck M, Fuller D. Breslin S, et al. Soc Sci Med. 2019 Jul;232:50-57. doi: 10.1016/j.socscimed.2019.04.035. Epub 2019 Apr 25. Soc Sci Med. 2019. PMID: 31059869
Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles.
Martinez VG, O'Neill S, Salimu J, Breslin S, Clayton A, Crown J, O'Driscoll L. Martinez VG, et al. Among authors: breslin s. Oncoimmunology. 2017 Aug 11;6(12):e1362530. doi: 10.1080/2162402X.2017.1362530. eCollection 2017. Oncoimmunology. 2017. PMID: 29209569 Free PMC article.
Neratinib resistance and cross-resistance to other HER2-targeted drugs due to increased activity of metabolism enzyme cytochrome P4503A4.
Breslin S, Lowry MC, O'Driscoll L. Breslin S, et al. Br J Cancer. 2017 Feb 28;116(5):620-625. doi: 10.1038/bjc.2016.445. Epub 2017 Feb 2. Br J Cancer. 2017. PMID: 28152547 Free PMC article.
The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance.
Breslin S, O'Driscoll L. Breslin S, et al. Oncotarget. 2016 Jul 19;7(29):45745-45756. doi: 10.18632/oncotarget.9935. Oncotarget. 2016. PMID: 27304190 Free PMC article.
Receptor tyrosine kinase targeting in multicellular spheroids.
Breslin S, O'Driscoll L. Breslin S, et al. Methods Mol Biol. 2015;1233:161-8. doi: 10.1007/978-1-4939-1789-1_15. Methods Mol Biol. 2015. PMID: 25319898
Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors.
Rani S, Corcoran C, Shiels L, Germano S, Breslin S, Madden S, McDermott MS, Browne BC, O'Donovan N, Crown J, Gogarty M, Byrne AT, O'Driscoll L. Rani S, et al. Among authors: breslin s. Cancer Res. 2014 Jul 15;74(14):3821-33. doi: 10.1158/0008-5472.CAN-13-2053. Epub 2014 May 29. Cancer Res. 2014. PMID: 24876102 Free article.
miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.
Corcoran C, Rani S, Breslin S, Gogarty M, Ghobrial IM, Crown J, O'Driscoll L. Corcoran C, et al. Among authors: breslin s. Mol Cancer. 2014 Mar 24;13:71. doi: 10.1186/1476-4598-13-71. Mol Cancer. 2014. PMID: 24655723 Free PMC article.
Deployment of lean six sigma in care coordination: an improved discharge process.
Breslin SE, Hamilton KM, Paynter J. Breslin SE, et al. Prof Case Manag. 2014 Mar-Apr;19(2):77-83; quiz 84-5. doi: 10.1097/NCM.0000000000000016. Prof Case Manag. 2014. PMID: 24496130
Consent: teaching how to give and take.
Breslin S, Bell PR, Cullen JR. Breslin S, et al. Ulster Med J. 2012 Sep;81(3):155-6. Ulster Med J. 2012. PMID: 23620618 Free PMC article. No abstract available.
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback